Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Striatal dopamine transporter and receptor availability correlate with relative cerebral blood flow measured with [11C]PE2I, [18F]FE-PE2I and [11C]raclopride PET in healthy individuals.
Jonasson M, Frick A, Fazio P, Hjorth O, Danfors T, Axelsson J, Appel L, Furmark T, Varrone A, Lubberink M. Jonasson M, et al. J Cereb Blood Flow Metab. 2023 Jul;43(7):1206-1215. doi: 10.1177/0271678X231160881. Epub 2023 Mar 13. J Cereb Blood Flow Metab. 2023. PMID: 36912083 Free PMC article.
Use of 11C-PE2I PET in differential diagnosis of parkinsonian disorders.
Appel L, Jonasson M, Danfors T, Nyholm D, Askmark H, Lubberink M, Sörensen J. Appel L, et al. Among authors: jonasson m. J Nucl Med. 2015 Feb;56(2):234-42. doi: 10.2967/jnumed.114.148619. Epub 2015 Jan 15. J Nucl Med. 2015. PMID: 25593112 Free article.
Reduced serotonin synthesis and regional cerebral blood flow after anxiolytic treatment of social anxiety disorder.
Frick A, Åhs F, Appel L, Jonasson M, Wahlstedt K, Bani M, Merlo Pich E, Bettica P, Långström B, Lubberink M, Fredrikson M, Furmark T. Frick A, et al. Among authors: jonasson m. Eur Neuropsychopharmacol. 2016 Nov;26(11):1775-1783. doi: 10.1016/j.euroneuro.2016.09.004. Epub 2016 Sep 15. Eur Neuropsychopharmacol. 2016. PMID: 27642077 Clinical Trial.
Expression and co-expression of serotonin and dopamine transporters in social anxiety disorder: a multitracer positron emission tomography study.
Hjorth OR, Frick A, Gingnell M, Hoppe JM, Faria V, Hultberg S, Alaie I, Månsson KNT, Wahlstedt K, Jonasson M, Lubberink M, Antoni G, Fredrikson M, Furmark T. Hjorth OR, et al. Among authors: jonasson m. Mol Psychiatry. 2021 Aug;26(8):3970-3979. doi: 10.1038/s41380-019-0618-7. Epub 2019 Dec 10. Mol Psychiatry. 2021. PMID: 31822819
Expectancy effects on serotonin and dopamine transporters during SSRI treatment of social anxiety disorder: a randomized clinical trial.
Hjorth OR, Frick A, Gingnell M, Hoppe JM, Faria V, Hultberg S, Alaie I, Månsson KNT, Rosén J, Reis M, Wahlstedt K, Jonasson M, Lubberink M, Antoni G, Fredrikson M, Furmark T. Hjorth OR, et al. Among authors: jonasson m. Transl Psychiatry. 2021 Nov 3;11(1):559. doi: 10.1038/s41398-021-01682-3. Transl Psychiatry. 2021. PMID: 34732695 Free PMC article. Clinical Trial.
Serotonin and dopamine transporter availability in social anxiety disorder after combined treatment with escitalopram and cognitive-behavioral therapy.
Hjorth O, Frick A, Gingnell M, Engman J, Björkstrand J, Faria V, Alaie I, Carlbring P, Andersson G, Jonasson M, Lubberink M, Antoni G, Reis M, Wahlstedt K, Fredrikson M, Furmark T. Hjorth O, et al. Among authors: jonasson m. Transl Psychiatry. 2022 Oct 7;12(1):436. doi: 10.1038/s41398-022-02187-3. Transl Psychiatry. 2022. PMID: 36202797 Free PMC article. Clinical Trial.
43 results